Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1997 2
1999 1
2000 1
2001 1
2002 2
2008 1
2009 3
2012 3
2014 1
2016 1
2017 1
2019 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators. Torres VE, et al. N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121377 Free PMC article. Clinical Trial.
Management of diabetic nephropathy.
Foggensteiner L, Mulroy S, Firth J. Foggensteiner L, et al. J R Soc Med. 2001 May;94(5):210-7. doi: 10.1177/014107680109400504. J R Soc Med. 2001. PMID: 11385086 Free PMC article. Review. No abstract available.
Risk Factors for Severe Renal Disease in Bardet-Biedl Syndrome.
Forsythe E, Sparks K, Best S, Borrows S, Hoskins B, Sabir A, Barrett T, Williams D, Mohammed S, Goldsmith D, Milford DV, Bockenhauer D, Foggensteiner L, Beales PL. Forsythe E, et al. Among authors: foggensteiner l. J Am Soc Nephrol. 2017 Mar;28(3):963-970. doi: 10.1681/ASN.2015091029. Epub 2016 Sep 22. J Am Soc Nephrol. 2017. PMID: 27659767 Free PMC article.
Revascularization versus medical therapy for renal-artery stenosis.
ASTRAL Investigators; Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lipkin G, Nicholson A, Scoble J. ASTRAL Investigators, et al. N Engl J Med. 2009 Nov 12;361(20):1953-62. doi: 10.1056/NEJMoa0905368. N Engl J Med. 2009. PMID: 19907042 Free article. Clinical Trial.
How can we make renal medicine careers more appealing to UK trainees?
Karangizi AHK, Chanouzas D, Mahdi A, Foggensteiner L. Karangizi AHK, et al. Among authors: foggensteiner l. Clin Kidney J. 2019 Feb 6;12(5):756-759. doi: 10.1093/ckj/sfz002. eCollection 2019 Oct. Clin Kidney J. 2019. PMID: 31583100 Free PMC article.
20 results